The development of anti-NPY1 receptor antibodies for research into and treatment of cardiovascular diseases and cancer
- Research Opportunity
- PhD
- Department
- Medicine and Radiology
- Location
- Austin Health
| Primary Supervisor | Number | Webpage | |
|---|---|---|---|
| Dr Peter J Wookley | pwookey@unimelb.edu.au | +61 (03) 9496 3584 | Personal web page |
Summary Research into the developement of an immunotoxin or imaging reagent for potential treatment or imaging of CVD and breast cancer respectively.
Project Details
NPY is an important hormone and via one of its targets, NPY1 receptor, induces vasoconstriction and thickening of the neo-intima in cardiovascular disease (CVD). This receptor is also expressed by cancer cells of the breast. An anti-human NPY1 receptor antibody has been developed against a unique target in the extracellular domain of the receptor. This antibody will be developed as an immunotoxin or imaging reagent for potential treatment or imaging of CVD and breast cancer respectively.
Faculty Research Themes
School Research Themes
Cancer in Medicine, Cardiometabolic
Research Opportunities
PhD
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
Key Contact
For further information about this research, please contact a supervisor.
Department
Research Group / Unit / Centre
Cardiovascular and Tumourivascular Laboratory
Research Node
Austin HealthMDHS Research library
Explore by researcher, school, project or topic.